UBS AM’s Achillion Pharmaceuticals, Inc. ACHN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q1
Sell
-714,432
Closed -$4.31M 2569
2019
Q4
$4.31M Buy
714,432
+532,918
+294% +$3.21M ﹤0.01% 1254
2019
Q3
$653K Buy
181,514
+8,681
+5% +$31.3K ﹤0.01% 2157
2019
Q2
$463K Buy
172,833
+84,513
+96% +$226K ﹤0.01% 2247
2019
Q1
$261K Buy
88,320
+5,000
+6% +$14.8K ﹤0.01% 2366
2018
Q4
$132K Hold
83,320
﹤0.01% 2485
2018
Q3
$307K Hold
83,320
﹤0.01% 2275
2018
Q2
$236K Buy
83,320
+3,800
+5% +$10.8K ﹤0.01% 2408
2018
Q1
$295K Buy
79,520
+14,881
+23% +$55.2K ﹤0.01% 2219
2017
Q4
$186K Hold
64,639
﹤0.01% 2335
2017
Q3
$290K Buy
64,639
+970
+2% +$4.36K ﹤0.01% 2097
2017
Q2
$292K Buy
63,669
+10,000
+19% +$45.9K ﹤0.01% 2047
2017
Q1
$226K Buy
53,669
+24,471
+84% +$103K ﹤0.01% 2134
2016
Q4
$121K Sell
29,198
-37,800
-56% -$157K ﹤0.01% 2219
2016
Q3
$543K Hold
66,998
﹤0.01% 1935
2016
Q2
$523K Hold
66,998
﹤0.01% 1934
2016
Q1
$517K Buy
66,998
+1,039
+2% +$8.02K ﹤0.01% 1901
2015
Q4
$712K Sell
65,959
-580,200
-90% -$6.26M ﹤0.01% 1878
2015
Q3
$4.47M Sell
646,159
-9,300
-1% -$64.3K ﹤0.01% 1098
2015
Q2
$5.81M Buy
655,459
+17,000
+3% +$151K 0.01% 1022
2015
Q1
$6.3M Buy
638,459
+10,200
+2% +$101K 0.01% 1001
2014
Q4
$7.7M Buy
628,259
+149,300
+31% +$1.83M 0.01% 941
2014
Q3
$4.78M Buy
478,959
+430,000
+878% +$4.29M ﹤0.01% 1043
2014
Q2
$371K Hold
48,959
﹤0.01% 2062
2014
Q1
$161K Buy
48,959
+8,800
+22% +$28.9K ﹤0.01% 2472
2013
Q4
$133K Sell
40,159
-2,061,906
-98% -$6.83M ﹤0.01% 2472
2013
Q3
$6.35M Buy
2,102,065
+516,300
+33% +$1.56M 0.01% 927
2013
Q2
$13M Buy
+1,585,765
New +$13M 0.02% 693